# Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ca-23-035-small-business-transition-grant-for-early-career-scientists/  
Official notice: https://www.grants.gov/search-results-detail/347688

> National Institutes of Health offered grants to small businesses. Applications closed on August 21, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-CA-23-035 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | August 21, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.172, 93.279, 93.286, 93.394 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in university laboratories, the NIH also supports innovative technology development in U.S. small businesses through its SBIR and STTR programs. As technologies transition from academic discovery to small businesses, two common challenges arise, identifying the right team with the right expertise to take the product into a small business, and funding for early-stage technology development. This FOA seeks to address both challenges simultaneously by having two equally important goals: entrepreneurial mentoring support, and product development support.

## Questions people ask

### Is RFA-CA-23-035 still open?

No. It closed on August 21, 2023.

### Who can apply for Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)?

Closed August 21, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-CA-23-035?

NIH RePORTER lists 8 projects funded under RFA-CA-23-035 in fiscal 2024 to 2026, at 4 institutions. The most were at Arma Bio, Inc., Atlas Biologics, LLC, Cosmyc Inc.

### Who has won Human Genome Research grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, University of Washington, The Broad Institute, Inc. The program made 1,255 awards worth $2.2 billion in that time.